Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Accumulated Expenses (2022 - 2025)

Neuraxis (NRXS) has disclosed Accumulated Expenses for 4 consecutive years, with $692683.0 as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 939.32% to $692683.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $692683.0 through Dec 2025, up 939.32% year-over-year, with the annual reading at $692683.0 for FY2025, 939.32% up from the prior year.
  • Accumulated Expenses hit $692683.0 in Q4 2025 for Neuraxis, down from $996238.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $1.3 million in Q2 2024 to a low of $26286.0 in Q2 2023.
  • Historically, Accumulated Expenses has averaged $390584.2 across 4 years, with a median of $71483.5 in 2023.
  • Biggest five-year swings in Accumulated Expenses: surged 4886.65% in 2024 and later crashed 94.92% in 2025.
  • Year by year, Accumulated Expenses stood at $834062.0 in 2022, then plummeted by 92.01% to $66648.0 in 2023, then changed by 0.0% to $66648.0 in 2024, then soared by 939.32% to $692683.0 in 2025.
  • Business Quant data shows Accumulated Expenses for NRXS at $692683.0 in Q4 2025, $996238.0 in Q3 2025, and $66648.0 in Q2 2025.